adplus-dvertising
Connect with us

News

First doses of Pfizer-BioNTech's COVID-19 vaccine arriving in Canada Sunday night – CBC.ca

Published

 on


The first doses of Pfizer-BioNTech’s COVID-19 vaccine will arrive in Canada on Sunday night, with more to follow on Monday, according to the military commander leading the national vaccine distribution effort.

Maj.-Gen. Dany Fortin, who is in charge of logistics at the Public Health Agency of Canada’s national operations centre, told CBC’s Chief Political Correspondent Rosemary Barton that he is confident provinces are prepared to receive and administer the first batch of approximately 30,000 doses.

“The delivery schedule is unfolding exactly as planned,” Fortin said in an interview on Rosemary Barton Live.

“Some flights will arrive tonight, some flights will arrive tomorrow, some trucks will cross the border tomorrow. So it’s all coming in the coming day or two.”

The impending delivery will set in motion a national immunization program of unprecedented scale that many hope will bring the coronavirus outbreak to an end and an eventual return to normalcy. The pandemic has killed more than 13,000 people in Canada and infected another 450,000.

“The provinces will be in a position to administer the vaccines in the coming days,” Fortin said. 

Logistical dry-runs

Fortin led a series of dry-runs last week to make sure everyone involved is comfortable handling the heat-sensitive shots — which must be stored at temperatures between –80 C and –60 C.

Because the Pfizer product is so temperature-sensitive, Pfizer contracted UPS to ship the doses directly from its plants to 14 point-of-use sites throughout Canada in order to limit movement and keep the vaccine stable. Most of those sites are at hospitals in major urban centres that have freezers capable of meeting the vaccine’s storage requirements.

Doses will be distributed on a per-capita basis, although Pfizer’s vaccine will not be sent to the territories for the time being as they currently lack the capacity to safely store the product.

Fortin said he expects provinces to increase the number of delivery sites capable of receiving vaccine shipments in the coming days.

“It depends per province — they might add one or two or three,” Fortin said. “When we’re at full speed, we’re probably going to have a couple of hundred sites for Pfizer-BioNTech product.”

Once the doses arrive, provinces will administer the vaccine to people in priority population groups, including front-line health-care workers, as well as residents and employees at long-term care homes. 

First Toronto doses going to long-term care workers

Dr. Kevin Smith, president and CEO of the University Health Network (UHN) in Toronto, said he expects doses of the vaccine to arrive at the hospital around midday Monday. UHN is one of two point-of-use sites in Ontario, along with The Ottawa Hospital.

The first 3,000 or so doses bound for Toronto will inoculate personal support workers and other employees at hard-hit long-term care homes in the Greater Toronto Area, Smith said. Employees are being given priority over residents because they can travel to the hospital to receive the vaccine.

“There is concern about the volatility of movement, so it’s been recommended that we not transport the vaccine until we have more experience with it,” Smith told Barton. “We’d likely use the Pfizer vaccine for long-term care workers and the Moderna vaccine would first go to long-term care residents.”

WATCH | CBC’s Chief Political Correspondent Rosemary Barton interviews Dr. Kevin Smith of University Health Network in Toronto:

COVID-19 vaccines are expected to arrive in Toronto midday Monday. Dr. Kevin Smith, president and CEO of the University Health Network, is overseeing next week’s vaccinations in Toronto. He says the first group that has been targeted to get the vaccine are long-term care facilities. 9:11

The Pfizer-BioNTech is a two-dose vaccine, with the second dose required 21 days after the first. According to data from clinical trials, immunity starts building 12 days after the first dose, but full protection isn’t in place until 28 days after the first shot.

Prime Minister Justin Trudeau announced on Dec. 7 that up to 249,000 doses of the two-dose Pfizer-BioNTech vaccine will be delivered before the end of the year. Officials have said they expect a total of six million vaccine doses from a variety of vaccine makers to arrive by the end of March 2021.

Details on upcoming shipments from Pfizer — including arrival dates and the number doses — are still being worked out with the company, Fortin said.

“The intent here is to ensure that we continue to have a regular drip feed of vaccines in the coming coming weeks,” he said.

Moderna vaccine next in line for approval

Canada became only the third country to give the green light to Pfizer-BioNTech’s COVID-19 vaccine when Health Canada authorized use of the vaccine for people over the age of 16 last Wednesday. The regulator concluded the vaccine was safe and approximately 95 per cent effective after a two-month review of the companies’ clinical trial data.

Three other vaccines are currently under review by Health Canada as part of a “rolling review process” that allows companies to submit data from clinical trials even as those trials are still underway. 

The vaccine candidates still under review are from U.S. biotechnology company Moderna; British pharmaceutical firm AstraZeneca in collaboration with Oxford University; and Janssen Inc., a pharmaceutical subsidiary of U.S.-based multinational Johnson & Johnson.

WATCH | CBC’s Chief Political Correspondent Rosemary Barton interviews Dr. Supriya Sharma of Health Canada:

Dr. Supriya Sharma with Health Canada is at the centre of the vaccine approval process. She says it’s now about the logistics and getting the COVID-19 vaccine out to the different sites in the country. 6:33

Dr. Supriya Sharma, Health Canada’s chief medical adviser, said Moderna is furthest along in the approval process, but the regulator still needs some data from the company before it can reach a decision. 

“We have some additional information on manufacturing of the Moderna vaccine that’s expected to come in sort of mid, late this week,” Sharma said. “We will be in a better place to give more accurate predictions in terms of the ending of the review once we get that information in.”

The U.S. Food and Drug Administration (FDA) has a meeting on Thursday, during which independent public health experts will discuss whether to grant emergency-use approval to Moderna’s vaccine. The FDA authorized Pfizer-BioNTech’s vaccine on Friday, just over 24 hours after a similar meeting.

Sharma said distribution plans are already being drawn up.

“Our reviewers are reviewing the [Moderna] vaccine, and the planning is taking place simultaneously so that everyone is ready when an authorization comes and the company is able to ship quickly — that the whole system is ready to be able to distribute and administer the vaccine,” Sharma said.

Fortin said his team is working with provinces and territories to be ready to receive doses of Moderna vaccine by the end of next week, although delivery isn’t expected until early January.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

News

My Boy Prince to race against older horses in $1-million Woodbine Mile

Published

 on

TORONTO – He’s firmly among Canada’s top three-year-olds but My Boy Prince faces a stiff test Saturday at Woodbine Racetrack.

The ’24 King’s Plate runner-up will be part of a global field in the $1-million Woodbine Mile turf event. Not only will it be My Boy Prince’s first race against older competition but among the seven other starters will be such horses as Naval Power (Great Britain), Big Rock (France) and Filo Di Arianna (Brazil).

My Boy Prince will race for the first time since finishing second to filly Caitlinhergrtness in the Plate on Aug. 23.

“It’s his first try against older horses and it’s hard to say where he fits in,” said trainer Mark Casse. “This time of year running a three-year-old against older horses, it’s like running a teenager against college athletes.

“We’re doing it because we believe a mile on the turf is his preferred surface … we wanted to give him a shot at this. (American owner Gary Barber) is someone who likes to think outside the box and take calculated risks so we’re going to see where he fits in.”

Casse, 16 times Canada’s top trainer, is a Hall of Famer both here and in the U.S. He’s also a two-time Woodbine Mile winner with filly Tepin (2016) and World Approval (2017).

Sahin Civaci will again ride My Boy Prince, Canada’s top two-year-old male who has six wins and 10 money finishes (6-3-1) in 11 career starts. The horse will be one of three Casse trainees in the race with Filo Di Arianna (ridden by Sovereign Award winner Kazushi Kimura) and Win for the Money (veteran Woodbine jockey Patrick Husbands aboard).

Naval Power, a four-year-old, has finished in the money in eight of nine starts (six wins, twice second) and will race in Canada for the first time. He comes to Woodbine with second-place finishes in two Grade 1 turf races.

Big Rock, another four-year-old, makes his North American debut Saturday. The horse has five wins and five second-place finishes in 14 starts but has struggled in ’24, finishing sixth, 10th and fifth in three races.

Filo Di Arianna is a four-time graded stakes winner with nine victories, three seconds and a third from 17 starts. It was Canada’s ’22 top male sprinter and champion male turf horse.

Other starters include Playmea Tune, Niagara Skyline and Secret Reserve.

Playmea Tune, a four-year-old, is trained by Josie Carrol. The gelding has made three starts, winning twice and finishing second in the Grade 3 Bold Venture on Aug. 23.

Woodbine-based Niagara Skyline is a six-year-old with 13 money finishes (six wins, five seconds, twice third) in 24-lifetime starts. The John Charlambous trainee has reached the podium (1-1-1) in all three races this year.

Secret Reserve, also a six-year-old, has finished in the money in 15-of-26 starts (six wins, one second, eight thirds). The horse, at 44-1, was third in the Grade 2 King Edward Stakes over a mile on the E.P. Taylor turf course.

The Mile highlights a stellar card featuring six graded stakes races. Also on tap are the $750,000 E.P. Taylor Stakes (fillies and mares), $500,000 bet365 Summer Stakes (two-year-olds) and $500,000 Johnnie Walker Natalma Stakes (two-year-old fillies), all Grade 1 turf events.

The Mile, Natalma and Summer winners earn automatic entries into the Breeders’ Cup at Del Mar in November.

Casse has won all four races, earning his first E.P. Taylor title last year with filly Fev Rover, Canada’s horse of the year and champion female turf horse. Fev Rover will defend her title Saturday against a field that includes Moira, the ’22 King’s Plate winner and Canada’s horse of the year trained by Woodbine’s Kevin Attard.

“It (E.P. Taylor) was definitely on my bucket list because it had eluded us,” Casse said. “But I honestly hadn’t realized I’d won all four of them, hadn’t really thought about it.”

Casse will have horses in all four turf races Saturday. Arguably the most intriguing matchup will be between Moira and Fev Rover, who ran 1-2, respectively, in a photo finish Aug. 11 in the Grade 2 Beverly D. Stakes, a 1 3/16-mile turf race, at Virginia’s Colonial Downs.

“What’s funny is the two of them went all the way to Virginia and she beat us by a nose,” Casse said. “We could’ve done that at Woodbine.

“There’s two of the best fillies in the world both from Toronto and they’re going to be competing Saturday.”

Some question having so many solid races on a single card but Casse likes the strategy.

“I think it’s a good thing,” he said. “On Saturday, the main focus on horse racing in the world will be on Woodbine and that’s because it’s such a great card.

“It’s an international day, there’s horses coming from everywhere and we’re going to do our best to represent Canada.”

This report by The Canadian Press was first published Sept. 13, 2024.



Source link

Continue Reading

News

Former world No. 1 Sharapova wins fan vote for International Tennis Hall of Fame

Published

 on

NEWPORT, R.I. (AP) — Maria Sharapova, a five-time Grand Slam singles champion, led the International Tennis Hall of Fame’s fan vote her first year on the ballot — an important part to possible selection to the hall’s next class.

The organization released the voting results Friday. American doubles team Bob and Mike Bryan finished second with Canada’s Daniel Nestor third.

The Hall of Fame said tens of thousands of fans from 120 countries cast ballots. Fan voting is one of two steps in the hall’s selection process. The second is an official group of journalists, historians, and Hall of Famers from the sport who vote on the ballot for the hall’s class of 2025.

“I am incredibly grateful to the fans all around the world who supported me during the International Tennis Hall of Fame’s fan votes,” Sharapova said in a statement. “It is a tremendous honor to be considered for the Hall of Fame, and having the fans’ support makes it all the more special.”

Sharapova became the first Russian woman to reach No. 1 in the world. She won Wimbledon in 2004, the U.S. Open in 2006 and the Australian Open in 2008. She also won the French Open twice, in 2012 and 2014.

Sharapova was also part of Russia’s championship Fed Cup team in 2008 and won a silver medal at the London Olympics in 2012.

To make the hall, candidates must receive 75% or higher on combined results of the official voting group and additional percentage from the fan vote. Sharapova will have an additional three percentage points from winning the fan vote.

The Bryans, who won 16 Grand Slam doubles titles, will have two additional percentage points and Nestor, who won eight Grand Slam doubles titles, will get one extra percentage point.

The hall’s next class will be announced late next month.

___

AP tennis:

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.



Source link

Continue Reading

Trending